SE8800613D0
(sv)
|
1988-02-23 |
1988-02-23 |
Wallac Oy |
A novel spectrofluorometric method and compounds that are of value for the method
|
JPH03287584A
(ja)
|
1990-04-05 |
1991-12-18 |
Banyu Pharmaceut Co Ltd |
置換アリルアミン誘導体
|
US5250534A
(en)
|
1990-06-20 |
1993-10-05 |
Pfizer Inc. |
Pyrazolopyrimidinone antianginal agents
|
US6200980B1
(en)
|
1995-06-07 |
2001-03-13 |
Cell Pathways, Inc. |
Method of treating a patient having precancerous lesions with phenyl purinone derivatives
|
TR199902646T2
(xx)
|
1997-04-25 |
2000-05-22 |
Pfizer Inc. |
Seks�el bozuklu�un tedavisi i�in pirazolopirimidinonlar.
|
CN1229349C
(zh)
|
1998-04-20 |
2005-11-30 |
美国辉瑞有限公司 |
吡啶-3-羧酸衍生物
|
JP2000038350A
(ja)
|
1998-05-18 |
2000-02-08 |
Yoshitomi Pharmaceut Ind Ltd |
糖尿病治療薬
|
GB9823101D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
GB9823102D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
IN187433B
(fr)
|
1999-09-10 |
2002-04-27 |
Cipla Ltd |
|
AU1888800A
(en)
|
1999-09-13 |
2001-04-17 |
Cipla Limited |
A novel process for the synthesis of sildenafil citrate
|
DE60037455T2
(de)
|
1999-09-17 |
2008-11-27 |
Abbott Gmbh & Co. Kg |
Kinaseinhibitoren als arzneimittel
|
HUP0203075A3
(en)
|
1999-09-24 |
2003-02-28 |
Nihon Nohyaku Co Ltd |
Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same
|
TWI265925B
(en)
|
1999-10-11 |
2006-11-11 |
Pfizer |
Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
|
JP2003511452A
(ja)
|
1999-10-11 |
2003-03-25 |
ファイザー・インク |
ホスホジエステラーゼ阻害剤としての5−(2−置換−5−ヘテロシクリルスルホニルピリド−3−イル)−ジヒドロピラゾロ[4,3−d]ピリミジン−7−オン
|
IL139073A0
(en)
|
1999-10-21 |
2001-11-25 |
Pfizer |
Treatment of neuropathy
|
KR100523718B1
(ko)
|
1999-12-22 |
2005-10-26 |
니혼노야쿠가부시키가이샤 |
방향족 디아미드 유도체, 농원예용 약제 및 이의 사용방법
|
CO5271697A1
(es)
|
2000-01-12 |
2003-04-30 |
Pfizer Prod Inc |
Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona
|
US20020013327A1
(en)
|
2000-04-18 |
2002-01-31 |
Lee Andrew G. |
Compositions and methods for treating female sexual dysfunction
|
AU1560802A
(en)
|
2000-06-28 |
2002-01-08 |
Smithkline Beecham Plc |
Wet milling process
|
AU2001277621A1
(en)
|
2000-08-09 |
2002-03-04 |
Astrazeneca Ab |
Antiangiogenic bicyclic derivatives
|
AU2001284417A1
(en)
|
2000-09-05 |
2002-03-22 |
Taisho Pharmaceutical Co. Ltd. |
Hair growth stimulants
|
US6548508B2
(en)
|
2000-10-20 |
2003-04-15 |
Pfizer, Inc. |
Use of PDE V inhibitors for improved fecundity in mammals
|
US7105532B2
(en)
|
2000-12-19 |
2006-09-12 |
Smithkline Beecham Corporation |
Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors
|
CZ20031776A3
(cs)
|
2000-12-19 |
2003-09-17 |
Merck Patent Gmbh |
Farmaceutický prostředek obsahující deriváty pyrazolo [4,3-d]-pyrimidinu a antitrombotika, vápníkové antagonisty, prostaglandiny nebo deriváty prostaglandinu (2)
|
US6784185B2
(en)
|
2001-03-16 |
2004-08-31 |
Pfizer Inc. |
Pharmaceutically active compounds
|
US6770645B2
(en)
|
2001-03-16 |
2004-08-03 |
Pfizer Inc. |
Pharmaceutically active compounds
|
EP1396493A4
(fr)
|
2001-04-26 |
2005-08-03 |
Ajinomoto Kk |
Composes heterocycliques
|
EP1383760A1
(fr)
|
2001-04-30 |
2004-01-28 |
Fujisawa Pharmaceutical Co., Ltd. |
Composes biarylcarboxamide comme inhibiteurs d'apolipoproteine b
|
FR2825706B1
(fr)
|
2001-06-06 |
2003-12-12 |
Pf Medicament |
Nouveaux derives de benzothienyle ou d'indole, leur preparation et leur utilisation comme inhibiteurs de proteines prenyl transferase
|
IL161155A0
(en)
|
2001-11-02 |
2004-08-31 |
Pfizer Prod Inc |
Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
|
TW200738672A
(en)
|
2001-12-10 |
2007-10-16 |
Bristol Myers Squibb Co |
Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
|
US7166293B2
(en)
|
2002-03-29 |
2007-01-23 |
Carlsbad Technology, Inc. |
Angiogenesis inhibitors
|
US20050119278A1
(en)
|
2002-05-16 |
2005-06-02 |
Che-Ming Teng |
Anti-angiogenesis methods
|
IL164209A0
(en)
|
2002-05-31 |
2005-12-18 |
Eisai Co Ltd |
Pyrazole derivatives and pharmaceutical compositions containing the same
|
CA2515571A1
(fr)
|
2003-02-14 |
2004-09-02 |
Wyeth |
Derives de heterocyclyl-3-sulfonylazaindole ou -azaindazole utilises comme ligands de la 5-hydroxytryptamine-6
|
JP4909068B2
(ja)
|
2003-02-14 |
2012-04-04 |
グラクソ グループ リミテッド |
カルボキサミド誘導体
|
WO2004087906A1
(fr)
|
2003-03-31 |
2004-10-14 |
Pfizer Products Inc. |
Structure cristalline de 3',5'-phosphodiesterase nucleotidique cyclique 1d(pde1b) et ses utilisations
|
EP1620437B1
(fr)
|
2003-04-29 |
2009-06-17 |
Pfizer Limited |
5,7-diaminopyrazolo 4,3-d]pyrimidines utiles pour le traitement de l'hypertension
|
WO2004108133A2
(fr)
|
2003-06-05 |
2004-12-16 |
Vertex Pharmaceuticals Incorporated |
Modulateurs du recepteur vr1
|
EP1635812A2
(fr)
|
2003-06-10 |
2006-03-22 |
Fulcrum Pharmaceuticals, Inc. |
Inhibiteurs de beta-lactamases et methodes d'utilisation de ces inhibiteurs
|
ZA200305330B
(en)
|
2003-07-10 |
2004-05-26 |
Jb Chemicals & Pharmaceuticals |
An improved process for the preparation of 5-[2-ethoxy-5-(4-methylpiperazin-1-ylsulphonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazole[4,3-D]P yrimidin-7-one.
|
RU2239637C1
(ru)
|
2003-07-17 |
2004-11-10 |
Дж.Б.Кемикалс Энд Фармасьютикалс Лтд. |
Улучшенный способ получения 5-[2-этокси-5-(4-метилпиперазин-1-илсульфонил)фенил]-1 метил-3-н-пропил-1,6-дигидро-7h-пиразол [4,3-d] пиримидин-7-она
|
US20080058515A1
(en)
|
2003-07-29 |
2008-03-06 |
David Harold Drewry |
Chemical Compounds
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
AU2004293436B2
(en)
|
2003-11-19 |
2010-12-09 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
US7241773B2
(en)
|
2003-12-22 |
2007-07-10 |
Abbott Laboratories |
3-quinuclidinyl heteroatom bridged biaryl derivatives
|
US20050137398A1
(en)
|
2003-12-22 |
2005-06-23 |
Jianguo Ji |
3-Quinuclidinyl heteroatom bridged biaryl derivatives
|
GB0402137D0
(en)
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
JP2007523938A
(ja)
|
2004-02-27 |
2007-08-23 |
エフ.ホフマン−ラ ロシュ アーゲー |
ピラゾールの縮合誘導体
|
KR100844864B1
(ko)
|
2004-02-27 |
2008-07-09 |
에프. 호프만-라 로슈 아게 |
헤테로아릴-융합 피라졸로 유도체
|
EP1720855A4
(fr)
|
2004-03-02 |
2008-12-17 |
Smithkline Beecham Corp |
Inhibiteurs de l'activite de la proteine kinase b (akt)
|
AR050188A1
(es)
|
2004-08-03 |
2006-10-04 |
Uriach Y Compania S A J |
Compuestos heterociclicos condensados utiles en terapia como inhibidores de quinasas p38 y composiciones farmaceuticas que los contienen
|
JP5143558B2
(ja)
|
2004-09-02 |
2013-02-13 |
ジェネンテック,インコーポレイティド |
ヘッジホッグシグナル伝達のピリジルインヒビター
|
WO2006038001A1
(fr)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Derives d’aminopyrimidine en tant qu’inhibiteurs de la jnk
|
WO2006045010A2
(fr)
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Stilbenes et chalcones utilises pour la prevention et le traitement de maladies cardio-vasculaires
|
AU2005299693B2
(en)
|
2004-10-26 |
2012-07-05 |
Janssen Pharmaceutica, N.V. |
Factor Xa compounds
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
EP1805136A1
(fr)
|
2004-10-28 |
2007-07-11 |
The Institutes for Pharmaceutical Discovery, LLC |
Acies phenylalcanoiques substitues
|
JP2008519850A
(ja)
|
2004-11-10 |
2008-06-12 |
シンタ ファーマシューティカルズ コーポレーション |
Il−12調節化合物
|
EP1812442A2
(fr)
|
2004-11-10 |
2007-08-01 |
CGI Pharmaceuticals, Inc. |
Certaines imidazo[1,2-a] pyrazin-8-ylamines et les procédés de fabrication et d'utilisation correspondants
|
US7919487B2
(en)
|
2004-11-10 |
2011-04-05 |
Synta Pharmaceuticals Corporation |
Heteroaryl compounds
|
DE102004054666A1
(de)
|
2004-11-12 |
2006-05-18 |
Bayer Cropscience Gmbh |
Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
CN100516049C
(zh)
|
2004-11-16 |
2009-07-22 |
永信药品工业股份有限公司 |
抗血管生成药n2-(取代的芳基甲基)-3-(取代的苯基)吲唑的合成
|
JP5038905B2
(ja)
|
2005-01-07 |
2012-10-03 |
エモリー・ユニバーシテイ |
医学的障害の治療用のcxcr4拮抗薬
|
AU2006230364B2
(en)
|
2005-03-31 |
2012-09-13 |
Janssen Pharmaceutica N.V. |
Bicyclic pyrazole compounds as antibacterial agents
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
US20100216798A1
(en)
|
2005-07-29 |
2010-08-26 |
Astellas Pharma Inc |
Fused heterocycles as lck inhibitors
|
CA2617532A1
(fr)
|
2005-08-04 |
2007-02-15 |
Sirtris Pharmaceuticals, Inc. |
Derives d'imidazo [2,1-b] thiazole en tant que modulateurs de sirtuine
|
GB0516703D0
(en)
|
2005-08-15 |
2005-09-21 |
Syngenta Participations Ag |
Novel insecticides
|
JP2007055940A
(ja)
|
2005-08-24 |
2007-03-08 |
Astellas Pharma Inc |
ピラゾロピリミジン誘導体
|
BRPI0615094A2
(pt)
|
2005-08-25 |
2011-05-03 |
Hoffmann La Roche |
inibidores de p38 map cinase e métodos de uso dos mesmos
|
MX2008002588A
(es)
|
2005-08-25 |
2008-03-18 |
Hoffmann La Roche |
Inhibidores de p38-map-cinasa y los metodos para utilizarlos.
|
KR101011957B1
(ko)
|
2005-08-25 |
2011-01-31 |
에프. 호프만-라 로슈 아게 |
P38 mαp 키나아제 저해제 및 이의 사용 방법
|
EP1922311A2
(fr)
|
2005-09-09 |
2008-05-21 |
Brystol-Myers Squibb Company |
Inhibiteurs d'ikur acycliques
|
WO2007041511A2
(fr)
|
2005-09-30 |
2007-04-12 |
New York University |
Kinase des progeniteurs hematopoietiques 1 destinee a la modulation d'une reponse immune
|
US20080242685A1
(en)
|
2005-10-25 |
2008-10-02 |
Smithkline Beecham Corporation |
Chemical Compounds
|
JP2009515837A
(ja)
|
2005-11-03 |
2009-04-16 |
イリプサ, インコーポレイテッド |
C4−酸性置換基を有するインドール化合物およびホスホリパーゼa2インヒビターとしてのその使用
|
BRPI0619208A2
(pt)
|
2005-11-30 |
2011-09-20 |
Astellas Pharma Inc |
derivado de 2-aminobenzamida c07d 307/14 c07d 307/22 c07d 309/14 c07d 319/12 c07d 401/12 c07d 405/12 c07d 413/12 c07d 417/12
|
GB0525143D0
(en)
|
2005-12-09 |
2006-01-18 |
Novartis Ag |
Organic compounds
|
JP2009523161A
(ja)
|
2006-01-11 |
2009-06-18 |
アストラゼネカ アクチボラグ |
モルホリノピリミジン誘導体と療法におけるその使用
|
WO2007093402A1
(fr)
|
2006-02-16 |
2007-08-23 |
Syngenta Participations Ag |
Pesticides contenant une structure bis(amide) bicyclique
|
JP2009530409A
(ja)
|
2006-03-23 |
2009-08-27 |
シンタ ファーマシューティカルズ コーポレーション |
炎症及び免疫関連使用用のベンゾイミダゾリル−ピリジン化合物
|
CN101454327A
(zh)
|
2006-03-30 |
2009-06-10 |
Irm责任有限公司 |
作为***素1活性抑制剂的吡咯并嘧啶类化合物
|
JP5420398B2
(ja)
|
2006-05-19 |
2014-02-19 |
アッヴィ・バハマズ・リミテッド |
Cns活性縮合ビシクロ複素環置換アザ二環式アルカン誘導体
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
WO2008008059A1
(fr)
|
2006-07-12 |
2008-01-17 |
Locus Pharmaceuticals, Inc. |
Agents anti-cancer et leurs utilisations
|
PE20080403A1
(es)
|
2006-07-14 |
2008-04-25 |
Amgen Inc |
Derivados heterociclicos fusionados y metodos de uso
|
GB0614691D0
(en)
|
2006-07-24 |
2006-08-30 |
Syngenta Participations Ag |
Insecticidal compounds
|
US20100087464A1
(en)
|
2006-10-06 |
2010-04-08 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
WO2008070313A2
(fr)
|
2006-10-20 |
2008-06-12 |
Concert Pharmaceuticals Inc. |
Dérivés de 3-(dihydro-1h-pyrazolo [4,3-d]pyrimidin-5-yl)-4-propoxybenzènesulfonamide et procédés d'utilisation
|
WO2008089307A2
(fr)
|
2007-01-18 |
2008-07-24 |
Lexicon Pharmaceuticals, Inc. |
Méthodes et compositions utilisés dans le traitement de la douleur, de l'inflammation et du cancer
|
WO2008089310A2
(fr)
|
2007-01-18 |
2008-07-24 |
Lexicon Pharmaceuticals, Inc. |
Méthodes et compositions utilisées dans le traitement de troubles corporels
|
EP2002835A1
(fr)
|
2007-06-04 |
2008-12-17 |
GenKyo Tex |
Dérivés de pyrazolo pyridine en tant qu'inhibiteurs de la NADPH oxydase
|
MY146643A
(en)
|
2007-07-30 |
2012-09-14 |
Dae Woong Pharma |
Novel benzoimidazole derivatives and pharmaceutical composition comprising the same
|
CN101790519B
(zh)
|
2007-08-08 |
2013-10-16 |
默克雪兰诺有限公司 |
用于治疗多发性硬化症的结合于鞘氨醇1-磷酸(s1p)的6-氨基-嘧啶-4-羧酰胺衍生物及相关化合物
|
GB0716414D0
(en)
|
2007-08-22 |
2007-10-03 |
Syngenta Participations Ag |
Novel insecticides
|
WO2009032651A1
(fr)
|
2007-08-31 |
2009-03-12 |
Smithkline Beecham Corporation |
INHIBITEURS DE L'ACTIVITÉ Akt
|
WO2009038784A1
(fr)
|
2007-09-21 |
2009-03-26 |
Amgen Inc. |
Composés hétéroaryliques fusionnés de triazole en tant qu'inhibiteurs de kinase p38
|
KR100963644B1
(ko)
|
2007-11-23 |
2010-06-15 |
한국과학기술연구원 |
피라졸로피리미딘온 유도체 및 그의 제조방법
|
AR069869A1
(es)
|
2007-12-21 |
2010-02-24 |
Exelixis Inc |
Derivados de benzofuro[3,2-d]pirimidinas inhibidores de proteinquinasas,composiciones farmaceuticas que los comprenden y usos de los mismos en el tratamiento del cancer.
|
JP5525456B2
(ja)
|
2008-02-04 |
2014-06-18 |
マーキュリー セラピューティクス,インコーポレイテッド |
Ampk調節因子
|
EP2273882A4
(fr)
|
2008-05-13 |
2011-07-13 |
Poniard Pharmaceuticals Inc |
Composés bioactifs pour le traitement du cancer et des maladies neurodégénératives
|
EA201001847A1
(ru)
|
2008-06-11 |
2011-08-30 |
Айрм Ллк |
Соединения и композиции, применяемые для лечения малярии
|
KR20110025224A
(ko)
|
2008-06-27 |
2011-03-09 |
아빌라 테라퓨틱스, 인크. |
헤테로아릴 화합물 및 이의 용도
|
WO2010029300A1
(fr)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Composés bis-aromatiques pour utilisation dans le traitement de l’inflammation
|
EP2165707A1
(fr)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Dérivés de pyrazolo pyridine en tant qu'inhibiteurs de la NADPH oxydase
|
EP2166008A1
(fr)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Dérivés de pyridine pyrazolo en tant qu'inhibiteurs d'oxydase NADPH
|
EP2166010A1
(fr)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Dérivés de pyridine pyrazolo en tant qu'inhibiteurs d'oxydase NADPH
|
US8703778B2
(en)
|
2008-09-26 |
2014-04-22 |
Intellikine Llc |
Heterocyclic kinase inhibitors
|
WO2010046780A2
(fr)
|
2008-10-22 |
2010-04-29 |
Institut Pasteur Korea |
Composés antiviraux
|
JP2010111624A
(ja)
|
2008-11-06 |
2010-05-20 |
Shionogi & Co Ltd |
Ttk阻害作用を有するインダゾール誘導体
|
MX2011006509A
(es)
|
2008-12-19 |
2011-10-19 |
Genentech Inc |
Compuestos heterociclicos y métodos de uso.
|
KR20100101054A
(ko)
|
2009-03-07 |
2010-09-16 |
주식회사 메디젠텍 |
세포핵에서 세포질로의 gsk3의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 gsk3 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물
|
AU2010226829A1
(en)
|
2009-03-18 |
2011-09-15 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
US9051185B2
(en)
|
2009-03-26 |
2015-06-09 |
Northeastern University |
Carbon nanostructures from pyrolysis of organic materials
|
WO2010118367A2
(fr)
|
2009-04-10 |
2010-10-14 |
Progenics Pharmaceuticals, Inc. |
Pyrimidines antivirales
|
US8846673B2
(en)
|
2009-08-11 |
2014-09-30 |
Bristol-Myers Squibb Company |
Azaindazoles as kinase inhibitors and use thereof
|
EP2477498A4
(fr)
|
2009-09-14 |
2013-02-27 |
Merck Sharp & Dohme |
Inhibiteurs de diacylglycérol acyltransférase
|
WO2011050245A1
(fr)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Hétéroaryles bicycliques formant inhibiteurs de la kinase
|
ES2360333B1
(es)
|
2009-10-29 |
2012-05-04 |
Consejo Superior De Investigaciones Cientificas (Csic) (70%) |
Derivados de bis (aralquil) amino y sistemas (hetero) aromaticos de seis miembros y su uso en el tratamiento de patologias neurodegenerativas, incluida la enfermedad de alzheimer
|
CA2780018C
(fr)
|
2009-11-12 |
2015-10-20 |
F. Hoffmann-La Roche Ag |
Composes de pyrazolopyrimidine et de purine n-7-substitues, compositions et procedes d'utilisation correspondants
|
JP2013032290A
(ja)
|
2009-11-20 |
2013-02-14 |
Dainippon Sumitomo Pharma Co Ltd |
新規縮合ピリミジン誘導体
|
WO2011078143A1
(fr)
|
2009-12-22 |
2011-06-30 |
塩野義製薬株式会社 |
Dérivés de pyrimidine et composition pharmaceutique les contenant
|
CA2784807C
(fr)
|
2009-12-29 |
2021-12-14 |
Dana-Farber Cancer Institute, Inc. |
Inhibiteurs de kinase raf de type ii
|
WO2011082400A2
(fr)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulateurs du récepteur immunosuppresseur pd-1 et procédés d'utilisation de ceux-ci
|
US20130109758A1
(en)
|
2010-01-06 |
2013-05-02 |
The University Of British Columbia |
Bisphenol derivative therapeutics and methods for their use
|
DE102010009903A1
(de)
|
2010-03-02 |
2011-09-08 |
Merck Patent Gmbh |
Verbindungen für elektronische Vorrichtungen
|
TW201200518A
(en)
|
2010-03-10 |
2012-01-01 |
Kalypsys Inc |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
CN102206172B
(zh)
|
2010-03-30 |
2015-02-25 |
中国医学科学院医药生物技术研究所 |
一组取代双芳基化合物及其制备方法和抗病毒应用
|
EP2560488B1
(fr)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Aminopyridines et aminotriazines, leurs compositions et leurs procédés d'utilisation
|
EP2563776B1
(fr)
|
2010-04-27 |
2016-06-08 |
Calcimedica, Inc. |
Composés capables de moduler le calcium intracellulaire
|
GB201008134D0
(en)
|
2010-05-14 |
2010-06-30 |
Medical Res Council Technology |
Compounds
|
JP2011246389A
(ja)
|
2010-05-26 |
2011-12-08 |
Oncotherapy Science Ltd |
Ttk阻害作用を有する縮環ピラゾール誘導体
|
BR112012030184A2
(pt)
|
2010-05-27 |
2015-12-29 |
Bayer Cropscience Ag |
derivados de ácido piridinilcarboxílico como fungicidas
|
WO2011153553A2
(fr)
|
2010-06-04 |
2011-12-08 |
The Regents Of The University Of California |
Méthodes et compositions pour l'inhibition de kinases
|
CN103068814B
(zh)
|
2010-06-15 |
2015-11-25 |
拜耳知识产权有限责任公司 |
邻氨基苯甲酸衍生物
|
WO2011158108A2
(fr)
|
2010-06-16 |
2011-12-22 |
Purdue Pharma L.P. |
Indoles à substitution aryle et leur utilisation
|
CA2806655A1
(fr)
|
2010-07-28 |
2012-02-02 |
Bayer Intellectual Property Gmbh |
Imidazo[1,2-b]pyridazines substituees
|
WO2012048058A2
(fr)
|
2010-10-06 |
2012-04-12 |
J-Pharma Co., Ltd. |
Développement de puissants inhibiteurs des transporteurs d'urate : composés conçus pour leur action uricosurique
|
GB201017345D0
(en)
|
2010-10-14 |
2010-11-24 |
Proximagen Ltd |
Receptor antagonists
|
MX2013006467A
(es)
|
2010-12-09 |
2013-10-01 |
Amgen Inc |
Compuestos biciclicos como inhibidores pim.
|
US20130253011A1
(en)
|
2010-12-17 |
2013-09-26 |
Syngenta Participations Ag |
Insecticidal compounds
|
WO2012093101A1
(fr)
|
2011-01-04 |
2012-07-12 |
Novartis Ag |
Composés indoliques ou analogues de ceux-ci utiles dans le traitement de la dégénérescence maculaire liée à l'âge (dmla)
|
ES2732311T3
(es)
|
2011-02-07 |
2019-11-21 |
Univ Washington |
Compuestos de manósidos y procedimientos de uso de los mismos
|
MX342310B
(es)
|
2011-03-28 |
2016-09-26 |
Hoffmann La Roche |
Compuestos de tiazolopirimidina.
|
CN103502226B
(zh)
|
2011-04-12 |
2015-08-19 |
株式会社钟根堂 |
用于cetp抑制剂的环烯基芳基衍生物
|
EP2699579B1
(fr)
|
2011-04-21 |
2015-10-07 |
Origenis GmbH |
Pyrazolo[4,3-d]pyrimidines utiles en tant qu'inhibiteurs de kinases
|
WO2012156367A1
(fr)
|
2011-05-17 |
2012-11-22 |
Bayer Intellectual Property Gmbh |
Imidazopyridazines amino-substituées en tant qu'inhibiteurs de kinase mknk1
|
US20140107151A1
(en)
|
2011-05-17 |
2014-04-17 |
Principia Biophama Inc. |
Tyrosine kinase inhibitors
|
UY34104A
(es)
|
2011-05-31 |
2013-01-03 |
Syngenta Participations Ag |
?compuestos derivados benzamídicos heterocíclicos, procesos e intermedios para su preparación, composiciones y métodos para su uso?.
|
EP2714692B1
(fr)
|
2011-06-01 |
2017-03-22 |
Bayer Intellectual Property GmbH |
Aminoimidazopyridazines substituées
|
ES2610366T3
(es)
|
2011-06-22 |
2017-04-27 |
Bayer Intellectual Property Gmbh |
Heterociclil-aminoimidazopiridazinas
|
EP2729146B1
(fr)
|
2011-07-08 |
2017-03-08 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Médicament pour le traitement du cancer du foie
|
EP2543372A1
(fr)
|
2011-07-08 |
2013-01-09 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Médicament pour le traitement du cancer du foie
|
WO2013021276A1
(fr)
|
2011-08-10 |
2013-02-14 |
Purdue Pharma L.P. |
Antagonistes du trpv1 comprenant un substituant dihydroxy et leurs utilisations
|
EP2742040B1
(fr)
|
2011-08-12 |
2016-04-06 |
F.Hoffmann-La Roche Ag |
Composes d'indazole, compositions pharmaceutiques et procedes d'utilisation de ceux-ci
|
BR112014003296A2
(pt)
|
2011-08-12 |
2017-03-14 |
Hoffmann La Roche |
composto, composição farmacêutica, processo para a preparação de uma composição farmacêutica, método para o tratamento de uma doença ou distúrbio, conjunto para o tratamento de uma condição mediada pela quinase pim e utilização do composto
|
WO2013042137A1
(fr)
|
2011-09-19 |
2013-03-28 |
Aurigene Discovery Technologies Limited |
Hétérocycles bicycliques convenant comme inhibiteurs de l'irak4
|
JP6174586B2
(ja)
|
2011-09-23 |
2017-08-02 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH |
置換イミダゾピリダジン
|
CN102503959B
(zh)
|
2011-10-25 |
2015-04-08 |
南方医科大学 |
一种稠三环类化合物及其制备方法、以及含该类化合物的药物组合物及其应用
|
CN102516263B
(zh)
|
2011-10-25 |
2015-04-08 |
南方医科大学 |
一种螺三环类化合物及其制备方法、以及含该类化合物的药物组合物及其应用
|
EP2773645A1
(fr)
|
2011-11-01 |
2014-09-10 |
F.Hoffmann-La Roche Ag |
Composés d'imidazopyridazine
|
BR112014020345B1
(pt)
|
2012-02-17 |
2021-09-21 |
Kineta Four Llc |
Composto antiviral, composição farmacêutica compreendendo dito composto e uso dos mesmos para tratar infecção viral ou doença associada à mesma
|
US9394297B2
(en)
|
2012-02-28 |
2016-07-19 |
Amgen Inc. |
Amides as pim inhibitors
|
TW201348231A
(zh)
|
2012-02-29 |
2013-12-01 |
Amgen Inc |
雜雙環化合物
|
CN104169260A
(zh)
|
2012-03-09 |
2014-11-26 |
卡尔那生物科学株式会社 |
新三嗪衍生物
|
WO2013146942A1
(fr)
|
2012-03-28 |
2013-10-03 |
出光興産株式会社 |
Nouveau composé, matériau pour élément électroluminescent organique, et élément électroluminescent organique
|
ES2571479T3
(es)
|
2012-04-20 |
2016-05-25 |
Gilead Sciences Inc |
Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH
|
WO2014003405A1
(fr)
|
2012-06-26 |
2014-01-03 |
주식회사 제이앤드제이 캐미칼 |
Nouveau composé et dispositif émettant de la lumière le comprenant
|
KR20150035766A
(ko)
|
2012-06-28 |
2015-04-07 |
노파르티스 아게 |
피롤리딘 유도체 및 보체 경로 조절제로서의 그의 용도
|
KR101936851B1
(ko)
|
2012-07-16 |
2019-01-11 |
한국과학기술연구원 |
단백질 키나아제 저해제인 신규 피라졸로피리딘 유도체 또는 인다졸 유도체
|
WO2014024125A1
(fr)
|
2012-08-08 |
2014-02-13 |
Celon Pharma S.A. |
Dérivés pyrazolo[4,3-d]pyrimidin-7(6h)-one comme inhibiteurs de pde9
|
WO2014030716A1
(fr)
|
2012-08-23 |
2014-02-27 |
田辺三菱製薬株式会社 |
Composé pyrazolopyrimidine
|
KR102124227B1
(ko)
|
2012-09-24 |
2020-06-17 |
아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 |
금속 화합물, 방법, 및 이의 용도
|
CA2887203A1
(fr)
|
2012-10-05 |
2014-04-10 |
Rigel Pharmaceuticals, Inc. |
Composes de pyrimidinyle substitues par 2,3-(heterooaryl et leur utilisation en tant qu'inhibiteurs gdf-8
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
KR102137472B1
(ko)
|
2013-02-08 |
2020-07-27 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
EP2968304B1
(fr)
|
2013-03-14 |
2018-10-10 |
The Trustees of Columbia University in the City of New York |
4-phénylpipéridines, leur préparation et leur utilisation
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
UY35464A
(es)
|
2013-03-15 |
2014-10-31 |
Araxes Pharma Llc |
Inhibidores covalentes de kras g12c.
|
US8853278B1
(en)
|
2013-05-22 |
2014-10-07 |
Curza Global, Llc |
Compositions comprising a biocidal polyamine
|
CN104232076B
(zh)
|
2013-06-10 |
2019-01-15 |
代表亚利桑那大学的亚利桑那校董会 |
具有改进的发射光谱的磷光四齿金属络合物
|
US9718818B2
(en)
|
2013-08-22 |
2017-08-01 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
TWI652014B
(zh)
|
2013-09-13 |
2019-03-01 |
美商艾佛艾姆希公司 |
雜環取代之雙環唑殺蟲劑
|
WO2015037965A1
(fr)
|
2013-09-16 |
2015-03-19 |
Rohm And Haas Electronic Materials Korea Ltd. |
Nouveaux composés électroluminescents organiques et dispositif électroluminescent organique les comprenant
|
CA2927924A1
(fr)
|
2013-10-18 |
2015-04-23 |
Syros Pharmaceuticals, Inc. |
Composes heteroaromatiques utiles pour le traitement des maladies proliferatives
|
KR20160063366A
(ko)
|
2013-10-21 |
2016-06-03 |
메르크 파텐트 게엠베하 |
Btk 저해제로서 헤테로아릴 화합물 및 이들의 용도
|
WO2015089327A1
(fr)
|
2013-12-11 |
2015-06-18 |
Biogen Idec Ma Inc. |
Composés biaryliques utiles pour le traitement de maladies humaines en oncologie, neurologie et immunologie
|
AU2014361798B2
(en)
|
2013-12-13 |
2020-06-11 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
TWI667233B
(zh)
|
2013-12-19 |
2019-08-01 |
德商拜耳製藥公司 |
新穎吲唑羧醯胺,其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
|
CN104725359B
(zh)
|
2013-12-20 |
2017-05-03 |
广东东阳光药业有限公司 |
取代的哌嗪化合物及其使用方法和用途
|
EA201691401A1
(ru)
|
2014-01-10 |
2016-11-30 |
Ориджин Дискавери Текнолоджиз Лимитед |
Индазольные соединения в качестве ингибиторов irak4
|
US11393988B2
(en)
|
2014-02-05 |
2022-07-19 |
Merck Patent Gmbh |
Metal complexes
|
MX2016011037A
(es)
|
2014-02-25 |
2017-02-28 |
Achillion Pharmaceuticals Inc |
Compuestos de fosfonato para el tratamiento de trastornos mediados por complemento.
|
US9871208B2
(en)
|
2014-02-26 |
2018-01-16 |
Samsung Display Co., Ltd. |
Condensed cyclic compound and organic light-emitting device including the same
|
WO2015164956A1
(fr)
|
2014-04-29 |
2015-11-05 |
The University Of British Columbia |
Composés dérivés de benzisothiazole utilisés comme agents thérapeutiques et leurs méthodes d'utilisation
|
US20150328188A1
(en)
|
2014-05-19 |
2015-11-19 |
Everardus O. Orlemans |
Combination Therapies for the Treatment of Proliferative Disorders
|
KR102402729B1
(ko)
|
2014-06-18 |
2022-05-26 |
메르크 파텐트 게엠베하 |
유기 전계발광 소자용 재료
|
US11279714B2
(en)
|
2014-06-20 |
2022-03-22 |
Institut Pasteur Korea |
Anti-infective compounds
|
CN106456609A
(zh)
|
2014-06-20 |
2017-02-22 |
奥瑞基尼探索技术有限公司 |
作为irak4抑制剂的取代的吲唑化合物
|
WO2015200682A1
(fr)
|
2014-06-25 |
2015-12-30 |
Vanderbilt University |
Analogues substitués de 4-alcoxypicolinamide en tant que modulateurs allostériques négatifs de mglur5
|
KR20160007967A
(ko)
|
2014-07-10 |
2016-01-21 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
WO2016040181A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040188A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040184A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040180A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016041618A1
(fr)
|
2014-09-15 |
2016-03-24 |
Merck Patent Gmbh |
Indazoles substitués et hétérocycles associés
|
AR102177A1
(es)
|
2014-10-06 |
2017-02-08 |
Merck Patent Gmbh |
Compuestos de heteroarilo como inhibidores de btk y usos de los mismos
|
WO2016071293A2
(fr)
|
2014-11-03 |
2016-05-12 |
Iomet Pharma Ltd |
Composé pharmaceutique
|
JO3705B1
(ar)
|
2014-11-26 |
2021-01-31 |
Bayer Pharma AG |
إندازولات مستبدلة جديدة، عمليات لتحضيرها، مستحضرات دوائية تحتوي عليها واستخدامها في إنتاج أدوية
|
WO2016090300A1
(fr)
|
2014-12-05 |
2016-06-09 |
Genentech, Inc. |
Procédés et compositions de traitement du cancer à l'aide d'antagonistes de l'axe pd-1 et d'antagonistes de hpk1
|
WO2016124304A1
(fr)
|
2015-02-03 |
2016-08-11 |
Merck Patent Gmbh |
Complexes métalliques
|
ES2872553T3
(es)
|
2015-03-06 |
2021-11-02 |
Pharmakea Inc |
Inhibidores de lisil oxidasa tipo-2 y usos de los mismos
|
CN107635984B
(zh)
|
2015-03-11 |
2021-04-13 |
Fmc公司 |
杂环取代的二环唑杀有害生物剂
|
WO2016161571A1
(fr)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de la btk de type indazole et azaindazole
|
US20180289685A1
(en)
|
2015-04-30 |
2018-10-11 |
Bayer Pharma Aktiengesellschaft |
Combinations of inhibitors of irak4 with inhibitors of btk
|
LT3322711T
(lt)
|
2015-06-25 |
2021-05-10 |
University Health Network |
Hpk1 inhibitoriai ir jų panaudojimo būdai
|
EP3322409A4
(fr)
|
2015-07-15 |
2019-07-24 |
Aurigene Discovery Technologies Limited |
Composés aza substitués comme inhibiteurs de l'irak-4
|
CU20180006A7
(es)
|
2015-07-15 |
2018-06-05 |
Aurigene Discovery Tech Ltd |
Compuestos de indazaol y azaindazol como inhibidores de irak-4
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023894A1
(fr)
|
2015-08-03 |
2017-02-09 |
Raze Therapeutics, Inc. |
Inhibiteurs de mthfd2 et utilisation desdits inhibiteurs
|
DK3331525T3
(da)
|
2015-08-07 |
2020-12-14 |
Calcimedica Inc |
Anvendelse af CRAC-kanal-inhibitorer til behandling af slagtilfælde og traumatisk hjerneskade
|
WO2017045955A1
(fr)
|
2015-09-14 |
2017-03-23 |
Basf Se |
Composés hétérobicycliques
|
WO2017058915A1
(fr)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibiteurs de protéines mutantes kras g12c
|
US20170107216A1
(en)
|
2015-10-19 |
2017-04-20 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
PL3377488T3
(pl)
|
2015-11-19 |
2022-12-19 |
Incyte Corporation |
Związki heterocykliczne jako immunomodulatory
|
US20170174671A1
(en)
|
2015-12-17 |
2017-06-22 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2017108744A1
(fr)
|
2015-12-22 |
2017-06-29 |
Bayer Pharma Aktiengesellschaft |
Nouveaux indazoles substitués, leurs procédés de préparation, préparations pharmaceutiques les contenant, et leur utilisation pour produire des médicaments
|
MD3394033T2
(ro)
|
2015-12-22 |
2021-04-30 |
Incyte Corp |
Compuși heterociclici ca imunomodulatori
|
US20170320875A1
(en)
|
2016-05-06 |
2017-11-09 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2017205464A1
(fr)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Composés hétérocycliques utilisés comme immunomodulateurs
|
MY197280A
(en)
|
2016-06-20 |
2023-06-09 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
EP3484866B1
(fr)
|
2016-07-14 |
2022-09-07 |
Incyte Corporation |
Composés hétérocycliques utilisés comme immunomodulateurs
|
WO2018044783A1
(fr)
|
2016-08-29 |
2018-03-08 |
Incyte Corporation |
Composés hétérocycliques utilisés comme immunomodulateurs
|
AR109595A1
(es)
|
2016-09-09 |
2018-12-26 |
Incyte Corp |
Compuestos de pirazolopirimidina y usos de estos como inhibidores de hpk1
|
US10280164B2
(en)
|
2016-09-09 |
2019-05-07 |
Incyte Corporation |
Pyrazolopyridone compounds and uses thereof
|
AU2017322427B2
(en)
|
2016-09-09 |
2021-12-23 |
Incyte Corporation |
Pyrazolopyridine derivatives as HPK1 modulators and uses thereof for the treatment of cancer
|
US20180072718A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
CN110312711A
(zh)
|
2016-10-07 |
2019-10-08 |
亚瑞克西斯制药公司 |
作为ras抑制剂的杂环化合物及其使用方法
|
WO2018119263A1
(fr)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Composés hétérocycliques utilisés en tant qu'inducteurs de l'internalisation de pd-l1
|
ES2899402T3
(es)
|
2016-12-22 |
2022-03-11 |
Incyte Corp |
Derivados de piridina como inmunomoduladores
|
KR20190111025A
(ko)
|
2016-12-22 |
2019-10-01 |
인사이트 코포레이션 |
면역조절제로서의 벤조옥사졸 유도체
|
EP3558963B1
(fr)
|
2016-12-22 |
2022-03-23 |
Incyte Corporation |
Composés hétéroaromatiques bicycliques utilisés en tant qu'immunomodulateurs
|
WO2018119236A1
(fr)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Dérivés de triazolo[1,5-a]pyridine en tant qu'immunomodulateurs
|
MD3558990T2
(ro)
|
2016-12-22 |
2023-02-28 |
Incyte Corp |
Derivați tetrahidro imidazo[4,5-c]piridină ca inductori de internalizare a PD-L1
|
US20180228786A1
(en)
|
2017-02-15 |
2018-08-16 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
US10722495B2
(en)
|
2017-09-08 |
2020-07-28 |
Incyte Corporation |
Cyanoindazole compounds and uses thereof
|
WO2019164847A1
(fr)
|
2018-02-20 |
2019-08-29 |
Incyte Corporation |
Composés d'indazole et leurs utilisations
|
US10745388B2
(en)
|
2018-02-20 |
2020-08-18 |
Incyte Corporation |
Indazole compounds and uses thereof
|
PL3755703T3
(pl)
|
2018-02-20 |
2022-11-07 |
Incyte Corporation |
Pochodne n-(fenylo)-2-(fenylo)pirymidyno-4-karboksyamidu i związki pokrewne jako inhibitory hpk1 do leczenia nowotworu
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|